- Home
- PDYN vs MNPR Comparison
PDYN vs MNPR Comparison
Compare PDYN & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDYN
- MNPR
- Stock Information
- Founded
- PDYN 1983
- MNPR 2014
- Country
- PDYN United States
- MNPR United States
- Employees
- PDYN N/A
- MNPR N/A
- Industry
- PDYN Wholesale Distributors
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- PDYN Industrials
- MNPR Health Care
- Exchange
- PDYN Nasdaq
- MNPR Nasdaq
- Market Cap
- PDYN 271.2M
- MNPR 244.1M
- IPO Year
- PDYN N/A
- MNPR 2019
- Fundamental
- Price
- PDYN $5.72
- MNPR $39.59
- Analyst Decision
- PDYN
- MNPR Strong Buy
- Analyst Count
- PDYN 0
- MNPR 5
- Target Price
- PDYN N/A
- MNPR $59.50
- AVG Volume (30 Days)
- PDYN 988.8K
- MNPR 27.1K
- Earning Date
- PDYN 05-07-2025
- MNPR 05-08-2025
- Dividend Yield
- PDYN N/A
- MNPR N/A
- EPS Growth
- PDYN N/A
- MNPR N/A
- EPS
- PDYN N/A
- MNPR N/A
- Revenue
- PDYN $7,786,000.00
- MNPR N/A
- Revenue This Year
- PDYN N/A
- MNPR N/A
- Revenue Next Year
- PDYN $105.66
- MNPR N/A
- P/E Ratio
- PDYN N/A
- MNPR N/A
- Revenue Growth
- PDYN 26.68
- MNPR N/A
- 52 Week Low
- PDYN $1.26
- MNPR $1.72
- 52 Week High
- PDYN $14.95
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- PDYN 42.65
- MNPR 57.10
- Support Level
- PDYN $5.28
- MNPR $26.06
- Resistance Level
- PDYN $6.59
- MNPR $40.90
- Average True Range (ATR)
- PDYN 0.62
- MNPR 4.78
- MACD
- PDYN 0.03
- MNPR 0.64
- Stochastic Oscillator
- PDYN 50.57
- MNPR 84.89
About PDYN Palladyne AI Corp.
Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.